Pharmaron Beijing Co., Ltd. (HKG:3759)
Hong Kong
· Delayed Price · Currency is HKD 13.72
+0.52 (3.94%)
Apr 24, 2025, 4:08 PM HKT
Pharmaron Beijing Market Cap
Pharmaron Beijing has a market cap or net worth of 40.33 billion as of April 24, 2025. Its market cap has increased by 9.17% in one year.
Market Cap
40.33B
Enterprise Value
44.07B
Revenue
13.06B
Ranking
n/a
PE Ratio
21.13
Stock Price
13.72
Market Cap Chart
Since January 28, 2019, Pharmaron Beijing's market cap has increased from 8.42B to 40.33B, an increase of 378.88%. That is a compound annual growth rate of 28.54%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 211.24B |
| Hansoh Pharmaceutical Group Company | 140.64B |
| JD Health International | 115.75B |
| WuXi Biologics | 87.23B |
| Innovent Biologics | 86.45B |
| Akeso | 79.35B |
| Alibaba Health Information Technology | 75.59B |
| CSPC Pharmaceutical Group | 69.44B |